Gene Therapies for Sickle Cell Casgevy Lyfgenia Insurance Cost Issues
Patient's blood sample tested positive for sickle cell anemia. Kitsawet Saethao | Stock | fake images The approval of two…
health care industry
Moderna (MRNA) Earnings in Q4 2023
Nikos Pekiaridis | Nurfoto | fake images modern It posted a surprise quarterly profit on Thursday, driven in part by…
Novavax to resolve Gavi arbitration over canceled Covid injection purchase
A healthcare worker prepares a dose of the Novavax vaccine as the Dutch Health Services Organization begins the Novavax vaccination…
Buy This Vertiv Data Center Company Despite Its Weak Guidance
Vertiv Holdings: The data center equipment maker, whose stock has roughly quadrupled over the past year, issued guidance that fell…
Alzheimer's drug Leqembi launched, nausea Apple Vision Pro
Good afternoon! The launch of the closely watched Alzheimer's drug Leqembi is off to a slow start. Even so, the…
Doctors Feeling Exhausted But Encouraged by AI's Potential, Survey Finds
Suriyapong Thongsawang | Moment | fake images Doctors in the United States are struggling to deal with burnout, staffing shortages…
AbbVie taps Robert Michael as CEO, replacing Richard González
Test tubes are seen in front of an AbbVie logo in this illustration taken on May 21, 2021. Ruvic Dice…
What you need to know about health coverage for new weight loss drugs
Many American companies are dealing with health insurance coverage issues for workers when it comes to GLP-1 weight loss drugs.…
In this fast-paced bull market, we are increasing our Club price targets by 4 stocks
It's been difficult to keep up. That's the story of this year's big stock winners. They keep winning and winning…
What Eli Lilly Investors Can Learn from the Slow Launch of a Rival Drug
Club holding company Eli Lilly hopes to win approval for its Alzheimer's treatment in the coming weeks, but investors looking…